bluebird bio (BLUE) PT Raised to $9 at BofA Securities
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $0.98 +2.08%
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 14 | New: 16
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 14 | New: 16
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry raised the price target on bluebird bio (NASDAQ: BLUE) to $9.00 (from $8.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
- Aecon Group (ARE:CN) (AEGXF) PT Raised to Cdn$22 at CIBC
- Bank of China Ltd (A-Shares) (601988:CH) PT Raised to RMB3.38 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
